Injectable Slow-Release Hydrogel Formulation of a Plant Virus-Based COVID-19 Vaccine Candidate-Reference-Cited by-同舟云学术

Injectable Slow-Release Hydrogel Formulation of a Plant Virus-Based COVID-19 Vaccine Candidate

Published:2022-03-28 Issue:4 Volume:23 Page:1812-1825
ISSN:1525-7797
Container-title:Biomacromolecules
language:en
Short-container-title:Biomacromolecules

Author:

Nkanga Christian Isalomboto¹,Ortega-Rivera Oscar A.¹²^ORCID,Shin Matthew D.¹²,Moreno-Gonzalez Miguel A.¹²^ORCID,Steinmetz Nicole F.¹³⁴²⁵^ORCID

Affiliation:

1. Department of NanoEngineering, University of California San Diego, 9500 Gilman Dr., La Jolla, California 92039, United States

2. Center for Nano-ImmunoEngineering, University of California San Diego, 9500 Gilman Dr., La Jolla, California 92039, United States

3. Department of Bioengineering, University of California San Diego, 9500 Gilman Dr., La Jolla, California 92039, United States

4. Department of Radiology, University of California San Diego, 9500 Gilman Dr., La Jolla, California 92039, United States

5. Moores Cancer Center, University of California San Diego, 9500 Gilman Dr., La Jolla, California 92039, United States

Funder

National Science Foundation

Publisher

American Chemical Society (ACS)

Subject

Materials Chemistry,Polymers and Plastics,Biomaterials,Bioengineering

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.biomac.2c00112

Reference86 articles.

1. A Novel Coronavirus from Patients with Pneumonia in China, 2019

2. World Health Organization. The True Death Toll of COVID-19. Https://Www.Who.Int/Data/Stories/the-True-Death-Toll-of-Covid-19-Estimating-Global-Excess-Mortality (Last accessed Dec 1 2021).

3. Statista. Number of Cumulative Cases of Coronavirus (COVID-19) Worldwide from January 22, 2020 to November 22, 2021. Https://Www.Statista.Com/Statistics/1103040/Cumulative-Coronavirus-Covid19-Cases-Number-Worldwide-by-Day/byDay (Last accessed on Dec 1, 2020).

4. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

5. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preparation of Alginic Acid/Poly(2‐Oxazoline) Hybrid Gels and Their Use in Cell Preservation;Macromolecular Materials and Engineering;2023-12-31

2. Sculpting DNA-based synthetic cells through phase separation and phase-targeted activity;Chem;2023-11

3. Viral nanoparticle vaccines against S100A9 reduce lung tumor seeding and metastasis;Proceedings of the National Academy of Sciences;2023-10-16

4. A Novel Formulation of Asparaginase Encapsulated into Virus-like Particles of Brome Mosaic Virus: In Vitro and In Vivo Evidence;Pharmaceutics;2023-08-31

5. Plant Viruses as Adjuvants for Next-Generation Vaccines and Immunotherapy;Vaccines;2023-08-16